Anwar Ahmed, MD
DESCRIPTION
Chorea is characterized by involuntary, rapid, brief, irregular movements that seemingly flow from one body part to another, thus giving the appearance of dancing. Chorea may be a manifestation of a neurodegenerative disease or a complication of systemic, toxic or metabolic diseases.
EPIDEMIOLOGY
Incidence/Prevalence
Incidence and prevalence is variable, depending on etiology.
RISK FACTORS
- Family history of chorea
- Exposure to certain medications
- Immunological factors
Genetics
Chorea can be seen with a number of hereditary conditions. Classic examples are Huntington's disease (HD) chorea, neuroacanthocytosis, and benign hereditary chorea.
GENERAL PREVENTION
Drug-induced chorea can be prevented by avoiding dopamine blocking drugs.
PATHOPHYSIOLOGY
Chorea is a hyperkinetic movement disorder caused by excessive dopaminergic activity may be associated with dopamine receptors super sensitivity.
ETIOLOGY
- Multiple etiologies of chorea:
- Genetic: HD, HD-like illnesses, neuroacanthocytosis, McLeod's syndrome, Wilson's disease (WD), benign hereditary chorea (BHC), spinocerebellar atrophy type 2, 3, and 17), Dentatorubropallidoluysian degeneration (DRPLA), ataxia-telangiectasia, ataxia associated with oculomotor apraxia, neuroferritinopathy, pantothenate kinase-associated degeneration, Leigh's disease and other mitochondriopathies and LeschNyhan disease
- Immunologic: Sydenham's chorea (SC), systemic lupus erythematosus, antiphospholipid antibody syndrome and paraneoplastic syndromes
- Drug/toxins: Amphetamine, anticonvulsants (Phenytoin), carbon monoxide, CNS stimulants (methylphenidate, pemoline, cyproheptadine), cocaine, dopamine agonists, dopamine-receptor blockers (Metoclopramide), ethanol, levodopa, levofloxacin, lithium, manganese, and mercury toxicity, sympathomimetics, theophylline, tricyclic antidepressants
- Infectious: HIV encephalitis, diphtheria, Scarlet fever, measles, mumps, West Nile encephalitis, neurocysticercosis, neurosyphilis, Lyme's disease, and toxoplasmosis
- Endocrine/metabolic dysfunction: Hyperthyroidism, chorea gravidarum, hypo- and hyperparathyroidism and Addison's disease. Renal or hepatic encephalopathy and other electrolyte abnormalities
- Vascular: Post-pump chorea (cardiac surgery), basal ganglia infarctions/hemorrhage, subdural hematoma
- Miscellaneous: Anoxic encephalopathy, cerebral palsy, Kernicterus, multiple sclerosis, nutritional (e.g., B12 deficiency), posttraumatic (brain injury)
COMMONLY ASSOCIATED CONDITIONS
- Benign hereditary chorea: Characterized by the onset of chorea in childhood, which is nonprogressive and self-limiting in most cases. Patient may have slight motor delay, ataxia and handwriting changes. Autosomal dominant illness, with a mutation in the TITF-1 gene.
- Essential/senile chorea: Adult onset chorea presents after age 60 nonprogressive and without dementia, psychiatric disturbance, or a family history of chorea and no other identifiable cause.
- HD: Autosomal dominant disease related to expansion of unstable stretch of CAG trinucleotide repeats in the huntington gene on chromosome 4p. It is characterized by chorea, ataxia, cognitive changes and psychiatric disturbances.
- Dentatorubropallidoluysian atrophy: Autosomal dominant trinucleotide (CAG) repeat disorder most prevalent in Japan. Manifested by variable combination of myoclonus, epilepsy, mental retardation in early onset before age 20 and in late onset manifested by ataxia, choreoathetosis, dystonia, and tremor
- WD: Autosomal recessive disease. The underlying defect is impaired biliary excretion of copper due to a defect in the WD gene, Wc1, on chromosome 13q, which encodes for a copper transporting adenosine triphosphatase (ATPase). Copper toxicity results in the deposition of copper initially in the liver and then the brain. Neurologic manifestations include tremor, chorea, dystonia, tics, myoclonus, ataxia, and Parkinsonism.
- Neuroacanthocytosis: It refers to a group of neurological disorders in which acanthocytes are seen on peripheral blood films: Several conditions can cause the combination of chorea and acanthocytosis.
- Choreoacanthocytosis: Patients have autosomal recessive inheritance showing linkage to chromosome 9q21. Symptoms first begin in 3rd4th decade of life with lip and tongue biting followed by orolingual dystonia, generalized chorea, and motor tics. Other features include cognitive and personality changes, seizures, dysphagia, dysarthria, parkinsonism, areflexia with evidence of axonal neuropathy.
- McLeod phenotype is an X-linked recessive form of acanthocytosis associated with chorea, personality disorder, seizures, depression but do not exhibit lip biting or dysphagia.
- Sydenham chorea: Most common form of autoimmune chorea worldwide, is a major feature of acute rheumatic fever (ARF), a complication of group A β-hemolytic Streptococcus infection. Clinically, it is characterized by a combination of chorea, behavioral abnormalities, and cognitive changes. The usual age at onset of SC is 89 years. Typically, patients develop this disease 48 weeks after an episode of group A β-hemolytic streptococcal pharyngitis. It does not occur after streptococcal infection of the skin. Pathogenesis of SC is related to circulating cross-reactive antibodies.
- Other autoimmune choreas: Other immunologic causes of chorea are systemic lupus erythematosus (SLE), primary antiphospholipid antibody syndrome (PAPS), and vasculitis. Autoimmune chorea has rarely been reported in the context of paraneoplastic syndromes associated with CV2/CRMP5 antibodies in patients with small-cell lung carcinoma or malignant thymoma.
- Vascular choreas: Chorea is an unusual complication of acute vascular lesions, seen in less than 1% of patients with acute stroke. Vascular hemichorea, or hemiballism, is usually related to ischemic or hemorrhagic lesions of the basal ganglia and adjacent white matter in the territory of the middle or the posterior cerebral artery. Another rare form of vascular chorea is postpump chorea, a complication of extracorporeal circulation.
Pregnancy Considerations
Chorea can occur during pregnancy, i.e., chorea gravidarum (CG), and typically resolves following delivery. However, the occurrence of CG may be the initial manifestation of systemic lupus erythematosus, HD, and the antiphospholipid antibody syndrome.
[Outline]
Diagnosis of chorea is based on history, physical examination, and diagnostic testing.
HISTORY
The clinical manifestations of chorea exist along a wide spectrum of diseases. History should include time of onset of chorea (acute, subacute or chronic). Exposure to drug and toxins should be excluded. Family or genetic history should be explored in detail. History of fever, infections and weight loss should be checked as well.
PHYSICAL EXAM
- In its mild form, patient may simply appear to be fidgety or restless; in its most extreme fashion, chorea can exist as large amplitude flinging movements of the proximal extremities, i.e., ballistic movements. Athetosis is a slow form of chorea and consists of slow writhing movements
- Memory: Usually is abnormal in HD
- Eye movements: Slow saccades is an early sign in HD
- Speech dysarthria can be seen in HD, SC and neuroacanthcytosis
- Patients with chorea exhibit motor impersistence (i.e., they cannot maintain a sustained posture). When attempting to grip an object, they alternately squeeze and release (milkmaid's grip). When they attempt to protrude the tongue, the tongue often pops in and out (harlequin's tongue)
- The muscle tone is usually decreased
- Deep tendon reflex may be delayed (hang up)
- Gait may be ataxic (HD and SC)
DIAGNOSTIC TESTS AND INTERPRETATION
Lab
- Serum and urine for drug/medication screen
- Serum glucose, sodium, calcium, phosphate, magnesium
- CBC and peripheral smear for acanthocytes
- Lipid profile (including lipoproteins)
- Endocrine studies: Thyroid function studies; PTH level
- For suspected WD: serum ceruloplasmin level; 24-hour urine collection for copper
- For suspected SLE: ANA, antidouble-stranded DNA antibodies, antiSmith antibodies
- For suspected rheumatic chorea: Antistreptolysin O titer, ESR, nose/throat culture, ECG, or echocardiogram
- For suspected APAS: VDRL (false-positive); platelet count (thrombocytopenia); aPTT (prolonged by at least 5 seconds and that does not correct with 1:1 dilution of the patient's plasma with normal or control plasma); lupus anticoagulant; and anticardiolipin antibody
- Paraneoplastic profile including CV2/CRMP5 antibodies in patients with small-cell lung
Imaging
Brain MRI may show
- Caudate atrophy in HD
- Caudate atrophy and white matter changes in neuroacanthocytosis
- T2 hyperintensity of the basal ganglia in WD
- T1 hyperintensity in putamen in hypermagnesemia
Diagnostic Procedures/Other
- Genetic testing for suspected HD and DRPLA; both are CAG repeat expansion disorders
- Slit-lamp examination for KayserFleischer rings in WD
Pathological Findings
- Cavitary necrosis of basal ganglia seen in WD
- Loss of medium spiny neurons in the striatum seen in HD
- Peripheral smear show acanthocytes in neuroacanthocytosis
DIFFERENTIAL DIAGNOSIS
- Other hyperkinetic movement disorders:
- Ticsrapid, nonrhythmic movements or suppressible for a short time
- Myoclonusrandom, irregular movements caused by rapid muscle contractions
- Dystoniacharacterized by sustained muscle contractions, resulting in twisting, repetitive, and patterned movements, or abnormal postures
- Tremorregular, rhythmic movement
- A pseudo-choreoathetosisdue to proprioceptive sensory loss
- Paroxysmal kinesigenic choreoathetosis
[Outline]
General Measures
Management of the patient with chorea is dependent on the etiology. In all patients, any underlying treatable or reversible condition should be ruled out, e.g., metabolic or endocrine disturbance, adverse effect of medications, structural lesion, stroke, multiple sclerosis. If female, the possibility of pregnancy should be investigated. WD should be ruled out in every child, adolescent, or young adult presenting with chorea or other movement disorder for which no cause can be found. Immunologic and paraneoplastic etiologies should be identified and treated as indicated.
MEDICATION
- Dopamine-receptor antagonistsantipsychotic medications
- Mechanism: Blockade of the D2 dopamine receptor; these include haloperidol, fluphenazine, perphenazine, trifluoperazine, and pimozide
- Dose: Initially with a small nightly dose (0.52 mg); titrate as needed for symptom control
- Adverse effects: Extrapyramidal side effectsacute dystonic reaction, neuroleptic malignant syndrome, Parkinsonism, tardive dyskinesia, and akathisia
- Precautions: An ECG should be obtained prior to the use of pimozide
- Dopamine depletors
- Tetrabenazine; Approved for HD chorea
- Mechanism: Reversible depletion of dopamine.
- Dose: 12.5100 mg/day
- Only rarely associated with acute dystonic reaction; tardive dyskinesia has not been seen. Monitor for depression, parkinsonism and orthostatic hypotension
- Reserpine: Can be used if Tetrabenzine is not available
- Methylprednisolone is an effective and well-tolerated treatment regimen for patients with SC refractory to conventional treatment with antichoreic drugs and penicillin
- Other medications: Use of Clonazepam, Clozaril, Amantadine, and Keppra has been shown to be beneficial in selected cases
SURGERY/OTHER PROCEDURES
Deep brain stimulation may provide benefit, in selected cases. There are case reports showing bilateral globus pallidus internus may be helpful for choreic movements.
[Outline]
FOLLOW-UP RECOMMENDATIONS
A comprehensive resource for movement disorder information. www.wemove.org
PATIENT EDUCATION
Genetic counseling: HD is inherited as an autosomal dominant fashion. Therefore, if there is a couple planning to conceive and one of the pair has HD, they should be educated that there is a 1-in-2 chance that each child they have could be affected.
PROGNOSIS
- Dependent on etiology:
- BHC and senile choreabenign course, life span is not threatened
- Inherited neurologic disorderstypically a more progressive disease course with shortened life span
- Chorea secondary to medications may be transient or persistent
- Chorea can recur in Sydenham's chorea, SLE, and APAS
COMPLICATIONS
- The severity of the abnormal involuntary movements may cause rhabdomyolysis or local trauma in some patients.
- The swallowing difficulties and tongue chorea usually present in neuroacanthocytosis patients may cause aspiration pneumonia and early death in some patients
[Outline]